Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional Study to Assess Tolerability of the Trivalent Recombinant Influenza Vaccine in Individuals Aged 18 Years and Older Using the Vaccinees Perception of Injection Questionnaire

NCT06765187 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06765187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06765187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional Study to Assess Tolerability of the Trivalent Recombinant Influenza Vaccine in Individuals Aged 18 Years and Older Using the Vaccinees Perception of Injection Questionnaire
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
November 18, 2024
Completion date
December 22, 2025
Enrollment
1,007 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health volunteers, influenza immunization